Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01387919
Other study ID # P10.164
Secondary ID
Status Completed
Phase N/A
First received July 1, 2011
Last updated July 8, 2011
Start date February 2011
Est. completion date March 2011

Study information

Verified date January 2011
Source Leiden University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Several studies have begun to determine the time course of events sensing energy availability in rodents. In contrast, there is not a single study that has examined this in humans to date. A better understanding of this energy sensing machinery in humans is of utmost importance to give us new insights into developing new therapies for common diseases such as obesity, diabetes mellitus, cardiovascular diseases and cancer. In these diseases, disturbances in the energy-sensing machinery possibly play a role. To determine the time course of energy sensing events in humans, the investigators will measure the concentration of various hormones in plasma, and biochemical changes in skeletal muscle at sequential time points during starvation in humans. The investigators choose to study the molecular machinery in muscle, since muscle is very sensitive to fuel deprivation.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 19 Years to 29 Years
Eligibility Inclusion Criteria:

- Healthy males

- Age 19-29 years old

- Body mass index (BMI) 19-25 kg/m2

- Stable weight for the last 3 months

- Caucasian

- Fasting plasma glucose (FPG) < 6 mmol/L

- Well-controlled blood pressure (< 150/95 mmHg)

- Creatinine <100 umol/l

- Hb > 7.5 mmol/l

- Negative family history (first degree) of type 2 diabetes mellitus (DM2)

Exclusion Criteria:

- Use of medication known to affect glucose metabolism (for example prednisone) or lipid metabolism

- Significant (chronic) disease

- Smoking (current)

- Alcohol consumption of more than 14 units per week at present or in the past

- Difficult accessible veins for insertion of an intravenous catheter

- Recent blood donation (within the last 3 months)

- Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year

- Rigorous exercise/sports 5 or more days a week

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Nutrient Sensing During a Prolonged Fast

Intervention

Behavioral:
Prolonged fasting
48 hours of fasting

Locations

Country Name City State
Netherlands Leiden University Medical Center Leiden Zuid-Holland

Sponsors (2)

Lead Sponsor Collaborator
Leiden University Medical Center Centre for Medical Systems Biology

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in several proteins/ribonucleic acid (RNA) from muscle biopsies upon fasting 1.5h, 4h, 10h, 24h No
Secondary Change in several hormones, lipids etc. from blood samples upon fasting 1.5h, 4h, 10h, 24h No